Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 261

1.

Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.

Otalora L, Chavez E, Watford D, Tueros L, Correa M, Nair V, Ruiz P, Wahl P, Eddy S, Martini S, Kretzler M, Burke GW 3rd, Fornoni A, Merscher S.

PLoS One. 2019 Oct 3;14(10):e0222948. doi: 10.1371/journal.pone.0222948. eCollection 2019.

2.

ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.

Ducasa GM, Mitrofanova A, Mallela SK, Liu X, Molina J, Sloan A, Pedigo CE, Ge M, Santos JV, Hernandez Y, Kim JJ, Maugeais C, Mendez AJ, Nair V, Kretzler M, Burke GW, Nelson RG, Ishimoto Y, Inagi R, Banerjee S, Liu S, Szeto HH, Merscher S, Fontanesi F, Fornoni A.

J Clin Invest. 2019 Jul 22;129(8):3387-3400. doi: 10.1172/JCI125316. eCollection 2019 Jul 22.

3.

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.

Mitrofanova A, Mallela SK, Ducasa GM, Yoo TH, Rosenfeld-Gur E, Zelnik ID, Molina J, Varona Santos J, Ge M, Sloan A, Kim JJ, Pedigo C, Bryn J, Volosenco I, Faul C, Zeidan YH, Garcia Hernandez C, Mendez AJ, Leibiger I, Burke GW, Futerman AH, Barisoni L, Ishimoto Y, Inagi R, Merscher S, Fornoni A.

Nat Commun. 2019 Jun 19;10(1):2692. doi: 10.1038/s41467-019-10584-4.

4.

Susceptibility-directed anticoagulation after pancreas transplantation: A single-center retrospective study.

Raveh Y, Ciancio G, Burke GW, Figueiro J, Chen L, Morsi M, Namias N, Singh BP, Lindsay M, Alfahel W, Sleem MS, Nicolau-Raducu R.

Clin Transplant. 2019 Jul;33(7):e13619. doi: 10.1111/ctr.13619. Epub 2019 Jun 23.

PMID:
31152563
5.

Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.

Camargo JF, Anjan S, Chin-Beckford N, Morris MI, Abbo LM, Simkins J, Ciancio G, Chen LJ, Burke GW, Figueiro J, Guerra G, Kupin WL, Mattiazzi A, Ortigosa-Goggins M, Ram Bhamidimarri K, Roth D.

Clin Transplant. 2019 May;33(5):e13532. doi: 10.1111/ctr.13532. Epub 2019 Apr 4.

PMID:
30866102
6.

The elusive podocyte crossmatch for recurrent focal segmental glomerulosclerosis.

Burke GW 3rd, Fornoni A.

Kidney Int. 2019 Mar;95(3):498-500. doi: 10.1016/j.kint.2018.11.032.

PMID:
30784659
7.

Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.

Mitrofanova A, Molina J, Varona Santos J, Guzman J, Morales XA, Ducasa GM, Bryn J, Sloan A, Volosenco I, Kim JJ, Ge M, Mallela SK, Kretzler M, Eddy S, Martini S, Wahl P, Pastori S, Mendez AJ, Burke GW, Merscher S, Fornoni A.

Kidney Int. 2018 Dec;94(6):1151-1159. doi: 10.1016/j.kint.2018.06.031. Epub 2018 Oct 6.

8.

Antibody-mediated rejection implies a poor prognosis in kidney transplantation: Results from a single center.

Ciancio G, Gaynor JJ, Guerra G, Sageshima J, Roth D, Chen L, Kupin W, Mattiazzi A, Tueros L, Ruiz P, Vianna R, Burke GW 3rd.

Clin Transplant. 2018 Oct;32(10):e13392. doi: 10.1111/ctr.13392. Epub 2018 Sep 23.

PMID:
30152116
9.

Roux-en-Y gastric bypass is an effective bridge to kidney transplantation: Results from a single center.

Thomas IA, Gaynor JJ, Joseph T, De La Cruz-Munoz N, Sageshima J, Kupin W, Chen LJ, Ciancio G, Burke GW 3rd, Mattiazzi AD, Roth D, Guerra G.

Clin Transplant. 2018 May;32(5):e13232. doi: 10.1111/ctr.13232. Epub 2018 Apr 10.

PMID:
29488657
10.

Never events and hospital-acquired conditions after kidney transplant.

Moghadamyeghaneh Z, Chen LJ, Alameddine M, Gupta AK, Burke GW, Ciancio G.

Can Urol Assoc J. 2017 Nov;11(11):E431-E436. doi: 10.5489/cuaj.4370.

11.

Case series: Transplantation of kidneys from donors with renal artery aneurysm.

Alameddine M, Moghadamyeghaneh Z, Guerra G, Morsi M, Osman M, Chia VJ, Burke GW, Chen L, Vianna R, Zheng I, González J, Ciancio G.

Can Urol Assoc J. 2017 Jul;11(7):E307-E310. doi: 10.5489/cuaj.4244. Epub 2017 Jul 11.

12.

Impact of antiretroviral therapy on clinical outcomes in HIV + kidney transplant recipients: Review of 58 cases.

Rosa R, Suarez JF, Lorio MA, Morris MI, Abbo LM, Simkins J, Guerra G, Roth D, Kupin WL, Mattiazzi A, Ciancio G, Chen LJ, Burke GW, Figueiro JM, Ruiz P, Camargo JF.

F1000Res. 2016 Dec 21;5:2893. doi: 10.12688/f1000research.10414.1. eCollection 2016.

13.

Randomized trial of rATg/Daclizumab vs. rATg/Alemtuzumab as dual induction therapy in renal transplantation: Results at 8years of follow-up.

Ciancio G, Gaynor JJ, Guerra G, Sageshima J, Roth D, Chen L, Kupin W, Mattiazzi A, Tueros L, Flores S, Hanson L, Ruiz P, Vianna R, Burke GW 3rd.

Transpl Immunol. 2017 Feb;40:42-50. doi: 10.1016/j.trim.2016.11.004. Epub 2016 Nov 22.

PMID:
27888093
14.

Pilot Randomized Trial of Tacrolimus/Everolimus vs Tacrolimus/Enteric-Coated Mycophenolate Sodium in Adult, Primary Kidney Transplant Recipients at a Single Center.

Ciancio G, Tryphonopoulos P, Gaynor JJ, Guerra G, Sageshima J, Roth D, Chen L, Kupin W, Mattiazzi A, Tueros L, Flores S, Hanson L, Powell RH, Ruiz P, Vianna R, Burke GW 3rd.

Transplant Proc. 2016 Jul-Aug;48(6):2006-10. doi: 10.1016/j.transproceed.2016.03.048.

PMID:
27569936
15.

Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.

Pedigo CE, Ducasa GM, Leclercq F, Sloan A, Mitrofanova A, Hashmi T, Molina-David J, Ge M, Lassenius MI, Forsblom C, Lehto M, Groop PH, Kretzler M, Eddy S, Martini S, Reich H, Wahl P, Ghiggeri G, Faul C, Burke GW 3rd, Kretz O, Huber TB, Mendez AJ, Merscher S, Fornoni A.

J Clin Invest. 2016 Sep 1;126(9):3336-50. doi: 10.1172/JCI85939. Epub 2016 Aug 2.

16.

Raising Awareness: The Need to Promote Allocation of Pancreata From Rare Nondiabetic Donors With Pancreatic Islet Autoimmunity to Type 1 Diabetes Research.

Burke GW 3rd, Posgai AL, Wasserfall CH, Atkinson MA, Pugliese A.

Am J Transplant. 2017 Jan;17(1):306-307. doi: 10.1111/ajt.13983. Epub 2016 Aug 24. No abstract available.

17.

Negative impact of prolonged cold storage time before machine perfusion preservation in donation after circulatory death kidney transplantation.

Paloyo S, Sageshima J, Gaynor JJ, Chen L, Ciancio G, Burke GW.

Transpl Int. 2016 Oct;29(10):1117-25. doi: 10.1111/tri.12818. Epub 2016 Aug 12.

18.

Biomarkers in pancreas transplant.

Burke GW 3rd, Chen LJ, Ciancio G, Pugliese A.

Curr Opin Organ Transplant. 2016 Aug;21(4):412-8. doi: 10.1097/MOT.0000000000000333. Review.

19.

Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients.

Lorio MA, Rosa R, Suarez JF, Ruiz P, Ciancio G, Burke GW, Camargo JF.

Transpl Immunol. 2016 Sep;38:40-43. doi: 10.1016/j.trim.2016.06.001. Epub 2016 Jun 11.

20.

Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients.

Suarez JF, Rosa R, Lorio MA, Morris MI, Abbo LM, Simkins J, Guerra G, Roth D, Kupin WL, Mattiazzi A, Ciancio G, Chen LJ, Burke GW, Goldstein MJ, Ruiz P, Camargo JF.

Am J Transplant. 2016 Aug;16(8):2463-72. doi: 10.1111/ajt.13782. Epub 2016 Apr 4.

21.

Renal Transplantation in a Patient With Unsuspected Inferior Vena Cava Obliteration.

Lugo-Baruqui JA, Velásquez CA, Chen LJ, Ciancio G, Burke GW.

Transplantation. 2016 Oct;100(10):2230-3. doi: 10.1097/TP.0000000000001039.

PMID:
26863471
22.

Ten-Year Follow-up of a Reused Kidney Graft for Transplant Using Sirolimus for Maintenance Immunosuppression.

Lugo-Baruqui J, Burke GW, Guerra G, Ruiz P, Ciancio G.

Transplant Proc. 2015 Dec;47(10):3027-30. doi: 10.1016/j.transproceed.2015.10.031.

PMID:
26707333
23.

Use of Kidneys with Small Renal Tumors for Transplantation.

Lugo-Baruqui A, Guerra G, Arocha A, Burke GW, Ciancio G.

Curr Urol Rep. 2016 Jan;17(1):3. doi: 10.1007/s11934-015-0557-z. Review.

PMID:
26695405
24.

Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity.

Burke GW 3rd, Vendrame F, Virdi SK, Ciancio G, Chen L, Ruiz P, Messinger S, Reijonen HK, Pugliese A.

Curr Diab Rep. 2015 Dec;15(12):121. doi: 10.1007/s11892-015-0691-5. Review.

PMID:
26547222
25.

Lower tacrolimus trough levels are associated with subsequently higher acute rejection risk during the first 12 months after kidney transplantation.

Gaynor JJ, Ciancio G, Guerra G, Sageshima J, Roth D, Goldstein MJ, Chen L, Kupin W, Mattiazzi A, Tueros L, Flores S, Hanson L, Ruiz P, Vianna R, Burke GW 3rd.

Transpl Int. 2016 Feb;29(2):216-26. doi: 10.1111/tri.12699. Epub 2015 Nov 3.

26.

Nephrin Contributes to Insulin Secretion and Affects Mammalian Target of Rapamycin Signaling Independently of Insulin Receptor.

Villarreal R, Mitrofanova A, Maiguel D, Morales X, Jeon J, Grahammer F, Leibiger IB, Guzman J, Fachado A, Yoo TH, Busher Katin A, Gellermann J, Merscher S, Burke GW, Berggren PO, Oh J, Huber TB, Fornoni A.

J Am Soc Nephrol. 2016 Apr;27(4):1029-41. doi: 10.1681/ASN.2015020210. Epub 2015 Sep 23.

27.

Risk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas-Kidney Transplants.

Vendrame F, Hopfner YY, Diamantopoulos S, Virdi SK, Allende G, Snowhite IV, Reijonen HK, Chen L, Ruiz P, Ciancio G, Hutton JC, Messinger S, Burke GW 3rd, Pugliese A.

Am J Transplant. 2016 Jan;16(1):235-45. doi: 10.1111/ajt.13426. Epub 2015 Aug 28.

28.

Living donor renal transplantation with incidental renal cell carcinoma from donor allograft.

Lugo-Baruqui JA, Guerra G, Chen L, Burke GW, Gaite JA, Ciancio G.

Transpl Int. 2015 Sep;28(9):1126-30. doi: 10.1111/tri.12594. Epub 2015 May 7.

29.

Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary kidney transplant recipients.

Gaynor JJ, Ciancio G, Guerra G, Sageshima J, Hanson L, Roth D, Goldstein MJ, Chen L, Kupin W, Mattiazzi A, Tueros L, Flores S, Barba LJ, Lopez A, Rivas J, Ruiz P, Vianna R, Burke GW 3rd.

Clin Transplant. 2015 Apr;29(4):301-10. doi: 10.1111/ctr.12510. Epub 2015 Feb 18.

PMID:
25581205
30.

Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant.

Gaynor JJ, Ciancio G, Guerra G, Sageshima J, Hanson L, Roth D, Goldstein MJ, Chen L, Kupin W, Mattiazzi A, Tueros L, Flores S, Barba LJ, Lopez A, Rivas J, Ruiz P, Vianna R, Burke GW 3rd.

Diabetologia. 2015 Feb;58(2):334-45. doi: 10.1007/s00125-014-3428-0. Epub 2014 Nov 1.

PMID:
25361829
31.

A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.

Delville M, Sigdel TK, Wei C, Li J, Hsieh SC, Fornoni A, Burke GW, Bruneval P, Naesens M, Jackson A, Alachkar N, Canaud G, Legendre C, Anglicheau D, Reiser J, Sarwal MM.

Sci Transl Med. 2014 Oct 1;6(256):256ra136. doi: 10.1126/scitranslmed.3008538.

32.

Retrieval of the pancreas allograft for whole-organ transplantation.

Fridell JA, Powelson JA, Kubal CA, Burke GW, Sageshima J, Rogers J, Stratta RJ.

Clin Transplant. 2014 Dec;28(12):1313-30. doi: 10.1111/ctr.12459. Epub 2014 Oct 16. Review.

PMID:
25203627
33.

Type 2 diabetes: is pancreas transplantation an option?

Ciancio G, Burke GW.

Curr Diab Rep. 2014;14(11):542. doi: 10.1007/s11892-014-0542-9. Review.

PMID:
25189435
34.

New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation.

Pugliese A, Vendrame F, Reijonen H, Atkinson MA, Campbell-Thompson M, Burke GW.

Curr Diab Rep. 2014 Oct;14(10):530. doi: 10.1007/s11892-014-0530-0. Review.

35.

Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.

Yoo TH, Pedigo CE, Guzman J, Correa-Medina M, Wei C, Villarreal R, Mitrofanova A, Leclercq F, Faul C, Li J, Kretzler M, Nelson RG, Lehto M, Forsblom C, Groop PH, Reiser J, Burke GW, Fornoni A, Merscher S.

J Am Soc Nephrol. 2015 Jan;26(1):133-47. doi: 10.1681/ASN.2013111213. Epub 2014 Jun 12.

36.

Issues in solid-organ transplantation in children: translational research from bench to bedside.

Lipshultz SE, Chandar JJ, Rusconi PG, Fornoni A, Abitbol CL, Burke GW 3rd, Zilleruelo GE, Pham SM, Perez EE, Karnik R, Hunter JA, Dauphin DD, Wilkinson JD.

Clinics (Sao Paulo). 2014;69 Suppl 1:55-72. Review.

37.

Everolimus with low-dose tacrolimus in simultaneous pancreas and kidney transplantation.

Sageshima J, Ciancio G, Chen L, Dohi T, El-Hinnawi A, Paloyo S, Misawa R, Ekwenna O, Yatawatta A, Burke GW 3rd.

Clin Transplant. 2014 Jul;28(7):797-801. doi: 10.1111/ctr.12381. Epub 2014 Jun 1.

PMID:
24779669
38.

Podocyte foot process effacement in postreperfusion allograft biopsies.

Burke GW, Chang JW, Pardo V, Sageshima J, Chen L, Ciancio G, Tsai HL, Wei C, Fornoni A.

Transplantation. 2014 Apr 15;97(7):e38-9. doi: 10.1097/TP.0000000000000053. No abstract available.

39.

Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C.

Hibi T, Nishida S, Sageshima J, Levi DM, Ruiz P, Roth D, Martin P, Okabayashi K, Burke GW, Ciancio G, Tzakis AG.

Transpl Int. 2014 Jun;27(6):606-16. doi: 10.1111/tri.12303. Epub 2014 Mar 31.

40.

Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy.

Sageshima J, Ciancio G, Chen L, Dohi T, El-Hinnawi A, Paloyo S, Gaynor JJ, Mattiazzi A, Guerra G, Kupin W, Roth D, Ruiz P, Burke GW 3rd.

Transpl Immunol. 2014 Mar;30(2-3):88-92. doi: 10.1016/j.trim.2014.01.003. Epub 2014 Feb 9.

PMID:
24518158
41.

Randomized trial of three induction antibodies in kidney transplantation: long-term results.

Ciancio G, Gaynor JJ, Guerra G, Sageshima J, Chen L, Mattiazzi A, Roth D, Kupin W, Tueros L, Flores S, Hanson L, Vianna R, Burke GW 3rd.

Transplantation. 2014 Jun 15;97(11):1128-38. doi: 10.1097/01.TP.0000441089.39840.66.

PMID:
24477186
42.

Graft failure due to noncompliance among 628 kidney transplant recipients with long-term follow-up: a single-center observational study.

Gaynor JJ, Ciancio G, Guerra G, Sageshima J, Hanson L, Roth D, Chen L, Kupin W, Mattiazzi A, Tueros L, Flores S, Aminsharifi J, Joshi S, Chediak Z, Ruiz P, Vianna R, Burke GW 3rd.

Transplantation. 2014 May 15;97(9):925-33. doi: 10.1097/01.TP.0000438199.76531.4a.

PMID:
24445926
43.

Successful treatment for graft-versus-host disease after pancreas transplantation.

Chang Jw, Sageshima J, Ciancio G, Mattiazzi A, Chen L, Tsai HL, Ruiz P, Burke GW 3rd.

Clin Transplant. 2014 Feb;28(2):217-22. doi: 10.1111/ctr.12300. Epub 2014 Jan 17.

PMID:
24433450
44.

Highly Sensitized Patients: Miami Transplant Institute Experience.

Mattiazzi AD, Centeno A, Amador A, Fernandez-Bango C, Scowby CD, O'Rourke M, Hill-Matthie T, Patel R, Barrios F, Ruiz P, Chen L, Saghesima J, Ciancio G, Burke GW, Goldstein M, Chandar J, Contreras G, Roth D, Kupin W, Guerra G, Vianna R.

Clin Transpl. 2014:171-8.

PMID:
26281142
45.

The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings.

Pugliese A, Yang M, Kusmarteva I, Heiple T, Vendrame F, Wasserfall C, Rowe P, Moraski JM, Ball S, Jebson L, Schatz DA, Gianani R, Burke GW, Nierras C, Staeva T, Kaddis JS, Campbell-Thompson M, Atkinson MA.

Pediatr Diabetes. 2014 Feb;15(1):1-9. doi: 10.1111/pedi.12097. Epub 2013 Dec 10. Review.

46.

Kidney allograft survival of African American and Caucasian American recipients with lupus.

Contreras G, Li H, Gonzalez-Suarez M, Isakova T, Scialla JJ, Pedraza F, Mattiazzi A, Diaz-Wong R, Sageshima J, Brito Y, Guerra G, Acevedo B, Sajid Ali A, Kershaw TJ, Chen L, Burke GW, Kupin W, Ciancio G, Roth D.

Lupus. 2014 Feb;23(2):151-8. doi: 10.1177/0961203313513819. Epub 2013 Dec 2.

PMID:
24297643
47.

Abatacept in B7-1-positive proteinuric kidney disease.

Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW 3rd, Mundel P.

N Engl J Med. 2013 Dec 19;369(25):2416-23. doi: 10.1056/NEJMoa1304572. Epub 2013 Nov 8.

48.

Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy.

Guzman J, Jauregui AN, Merscher-Gomez S, Maiguel D, Muresan C, Mitrofanova A, Diez-Sampedro A, Szust J, Yoo TH, Villarreal R, Pedigo C, Molano RD, Johnson K, Kahn B, Hartleben B, Huber TB, Saha J, Burke GW 3rd, Abel ED, Brosius FC, Fornoni A.

Diabetes. 2014 Feb;63(2):701-14. doi: 10.2337/db13-0752. Epub 2013 Oct 7.

49.

A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab.

Ciancio G, Sageshima J, Akpinar E, Gaynor JJ, Chen L, Zarak A, Hanson L, Tueros L, Guerra G, Mattiazzi A, Kupin W, Roth D, Ricordi C, Burke GW 3rd.

Transplantation. 2013 Nov 15;96(9):800-6. doi: 10.1097/TP.0b013e3182a0f68c.

50.

Cyclodextrin protects podocytes in diabetic kidney disease.

Merscher-Gomez S, Guzman J, Pedigo CE, Lehto M, Aguillon-Prada R, Mendez A, Lassenius MI, Forsblom C, Yoo T, Villarreal R, Maiguel D, Johnson K, Goldberg R, Nair V, Randolph A, Kretzler M, Nelson RG, Burke GW 3rd, Groop PH, Fornoni A; FinnDiane Study Group.

Diabetes. 2013 Nov;62(11):3817-27. doi: 10.2337/db13-0399. Epub 2013 Jul 8.

Supplemental Content

Loading ...
Support Center